House
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor,Engineered for Demanding Fleet Applications
Thunes and Hyperwallet, a PayPal Service, Expand Payout Access for Merchants Across Asia-Pacific
SAN FRANCISCO,Jan. 14,2025-- Thunes,the Smart Superhighway to move money around the world,today welcomesHyperwallet,a PayPal service for global payouts,as a Member of Thunes\' Direct Global Network. A
RSM ramps up Asia Hub capabilities with new RSM Hong Kong Advisory firm
SINGAPORE,Jan. 14,2025-- RSM Hong Kong Advisory is pleased to announce the official opening of its office on 15 January 2025.
Frost & Sullivan Recognizes RapidSOS with the 2024 Product Leadership Award for Enhancing Public Safety Through Next-Gen Emergency Response Technology
RapidSOS\'s transformative platforms leverage artificial intelligence (AI) and connected data from over 540 million connected devices,sensors and apps to streamline emergency communications and impro
Nature's Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq
ONTARIO,Calif.,Jan. 15,2025-- Nature\'s Miracle Holding Inc. (NASDAQ: NMHI) ("Nature\'s Miracle" or the "Company"),a leader in vertical farming technology and infrastructure,today
Vanpowers Unveiled Advanced Smart System at CES 2025: Redefining the Future of Intelligent Cycling
LAS VEGAS,Jan. 15,2025-- Vanpowers,a global leader in e-bike innovation,made waves at CES 2025 with its Advanced Smart System,a groundbreaking integration of adaptive technology set to redefine cyclin
AM Green and DP World Join Forces to Establish India as a Global Hub for Green Molecules
Aiming to export 2 MTPA of green fuels,this partnership positions India as a leader in global decarbonization efforts.
ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS
SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch
Verkada Expands Leadership Team to Drive JAPAC Channel Growth
Boudewijn Pesch Joins Verkada as Vice President of JAPAC Channel Sales SAN MATEO,Calif.,Jan. 15,2025-- Verkada,a leader in cloud-based physical security,today announced the appointment of Boudewijn P
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
NEW YORK,Jan. 15,2025-- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company"),a leading provider of OTC pharmaceutical cross-border e-commerce